References
- Singh A, Bajwa A, Shujaat A. Evidence-based review of the management of hepatic hydrothorax. Respiration. 2013;86(2):155–173. doi:10.1159/000346996.
- Krok KL. Hepatic hydrothorax: Current concepts. Clin Liver Dis (Hoboken). 2014;4(2):35–37. Augdoi:10.1002/cld.375.
- Benz F, Mohr R, Tacke F, Roderburg C. Pulmonary complications in patients with liver cirrhosis. J Transl Int Med. 2020;8(3):150–158. Sepdoi:10.2478/jtim-2020-0024.
- Porcel JM. Management of refractory hepatic hydrothorax. Curr Opin Pulm Med. 2014; 20(4):352–357. doi:10.1097/MCP.0000000000000058.
- Baikati K, Le DL, Jabbour II, Singhal S, Anand S. Hepatic hydrothorax. Am J Ther. 2014; 21(1):43–51. doi:10.1097/MJT.0b013e318228319e.
- Baig MA, Majeed MB, Attar BM, Khan Z, Demetria M, Gandhi SR. Efficacy and safety of indwelling pleural catheters in management of hepatic hydrothorax: a systematic review of literature. Cureus. 2018;10(8):e3110. doi:10.7759/cureus.3110.
- Li P, Hosseini S, Zhang T, Amjadi K. Clinical predictors of successful and earlier removal of indwelling pleural catheters in benign pleural effusions. Respiration. 2019;98(3):239–245. doi:10.1159/000500428.
- Frost N, Ruwwe-Glösenkamp C, Raspe M, et al. Indwelling pleural catheters for non-malignant pleural effusions: report on a single centre’s 10 years of experience. BMJ Open Resp Res. 2020;7(1):e000501. doi:10.1136/bmjresp-2019-000501.
- Kniese C, Diab K, Ghabril M, Bosslet G. Indwelling pleural catheters in hepatic hydrothorax: a single-center series of outcomes and complications. Chest. 2019;155(2):307–314. doi:10.1016/j.chest.2018.07.001.
- Shojaee S, Rahman N, Haas K, et al. Indwelling tunneled pleural catheters for refractory hepatic hydrothorax in patients with cirrhosis: a multicenter study. Chest. 2019;155(3):546–553. doi:10.1016/j.chest.2018.08.1034.
- Siddiqui F, Siddiqui AH. Intrapleural Catheter. 2018.
- Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology. 1982;5(6):649–656.
- Fysh ET, Bielsa S, Budgeon CA, et al. Predictors of clinical use of pleurodesis and/or indwelling pleural catheter therapy for malignant pleural effusion. Chest. 2015;147(6):1629–1634. doi:10.1378/chest.14-1701.
- Chen TA, Lo GH, Lai KH. Risk factors for spontaneous bacterial empyema in cirrhotic patients with hydrothorax. Journal-Chinese Medical Association. 2003;66(10):579–586.
- Patil M, Dhillon SS, Attwood K, Saoud M, Alraiyes AH, Harris K. Management of benign pleural effusions using indwelling pleural catheters: a systematic review and meta-analysis. Chest. 2017;151(3):626–635. doi:10.1016/j.chest.2016.10.052.
- Sese E, Xiol X, Castellote J, Rodríguez-Fariñas E, Tremosa G. Low complement levels and opsonic activity in hepatic hydrothorax: its relationship with spontaneous bacterial empyema. J Clin Gastroenterol. 2003;36(1):75–77. doi:10.1097/00004836-200301000-00020.